SCIEQ1
Hepatobiliary & Pancreatic Diseases International
ELSEVIER
Hepatobiliary & Pancreatic Diseases International is an academic journal published by ELSEVIER. Identifiers: ISSN 1499-3872, eISSN 2352-9377. Indexed in SCIE. Metrics: JIF 4.4. Subject areas: GASTROENTEROLOGY & HEPATOLOGY. tlooto lists 206 papers from this journal.
CiteScore
-
Scopus citation metric
SJR
-
SCImago rank
SNIP
-
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 1499-3872
- eISSN
- 2352-9377
- Abbreviation
- HEPATOB PANCREAT DIS
- Publisher
- ELSEVIER
- Country
- -
Web of Science categories
SCIEGASTROENTEROLOGY & HEPATOLOGY
Scopus ASJC categories
No ASJC category data available.
Keywords
Gastroenterology & Hepatology
Papers in this journal
Recent papers
- Editorial: Breaking barriers in transplantation.
2026
- Irreversible electroporation for locally advanced pancreatic cancer in an HIV-positive patient.
2026
- Timing of endoscopic retrograde cholangiopancreatography in acute cholangitis: A cohort study in Colombia.
2026
- Conversion therapy with arterial reconstruction: Redefining the resect-ability of locally advanced pancreatic cancer.
2026
- Radiopathomics for prediction of early recurrence after curative resection in patients with hepatocellular carcinoma.
2026
Most cited papers
- Crosstalk of liver immune cells and cell death mechanisms in different murine models of liver injury and its clinical relevance
2017 · 72 citations
- Clinical Impact of Plasma TGF-β1 and Circulating TGF-β1 mRNA in Diagnosis of Hepatocellular Carcinoma
2008 · 41 citations
- Expression of c-erbB-2 oncogene protein, epidermal growth factor receptor, and TGF-β1 in human pancreatic ductal adenocarcinoma
2002 · 28 citations
- Chronic heaatitis virus infection increases the risk of aancreatic cancer: a meta-analysis
2013 · 20 citations
- Expression of prothymosin α predicts early recurrence and poor prognosis of hepatocellular carcinoma
2015 · 17 citations